Search Results

Keywords: tilray

Tilray to double domestic footprint with acquisition of Canadian marijuana cultivator

British Columbia-based Tilray plans to buy Natura Naturals Holdings for up to 70 million Canadian dollars ($52 million) to significantly increase its Canadian cannabis footprint. Natura Naturals – a subsidiary of Natura Naturals Holdings – owns one of Canada’s 126 cannabis cultivation licenses. Under the terms of the definitive agreement, Tilray said it will deliver […]

Read More

Tilray, Authentic Brands Group enter revenue-sharing deal for cannabis products

Tilray, the British Columbia-based cannabis heavyweight, signed a revenue-sharing agreement with Authentic Brands Group (ABG) to market and distribute consumer cannabis products within the New York-based firm’s brand portfolio. Under the terms of the agreement, Tilray will pay $100 million to ABG and up to $250 million in cash and stock upon achieving unspecified milestones. […]

Read More

Budweiser maker AB InBev teams with Tilray in $100 million deal to research marijuana-infused drinks

Two commercial giants from the worlds of beer and marijuana are teaming up to spend $100 million to research cannabis-infused beverages, the latest deal to pair a Canadian cannabis company with a major maker of alcoholic beverages. Belgium-based AB InBev (NYSE: BUD), which includes Budweiser in its huge portfolio of beer brands, is partnering with […]

Read More

Canadian medical cannabis firm Tilray eyes global reach in deal with Novartis subsidiary

British Columbia-based Tilray reached an agreement with a subsidiary of Swiss pharmaceutical giant Novartis AG in which the Canadian firm’s medical marijuana will eventually be produced and distributed in countries where MMJ is legal. Tilray’s deal with Quebec-based Sandoz AG is an extension of a letter of intent the companies signed in March to produce co-branded, nonsmokable and noncombustible […]

Read More

IGC Resources, Westleaf Cannabis close CA$20M raise, including Tilray investment

Alberta marijuana companies IGC Resources (TSXV: IGC.H) and Westleaf Cannabis closed a brokered private placement of 20 million Canadian dollars ($15 million), including CA$2.9 million from British Columbia-based Tilray. The capital raise was completed in connection with Westleaf’s proposed reverse takeover of IGC, which received conditional approval from the TSX Venture Exchange. The company plans to […]

Read More

Feds grant UC San Diego cannabis import license for product from Canada’s Tilray

In a rare move, the U.S. Drug Enforcement Administration approved the importation of marijuana extracts from Canada for a clinical trial, a decision that paves the way for additional research into the potential medical benefits of cannabis. New research into medical marijuana could persuade more U.S. physicians to recommend the drug, which could provide a boost […]

Read More

Cannabis firm Tilray cuts ties with Namaste Technologies following pledge party

A reportedly racy shareholder party hosted by Namaste Technologies has cost the Toronto company its business ties with fast-growing cannabis producer Tilray.

Officials with Tilray confirmed in an email to Marijuana Business Daily that it had “ended its relationship” with Namaste after a highly publicized “pledge party” the firm held for stockholders who promised not to sell company shares for 90 days.

Read More

Cannabis firm Tilray outlines IPO terms ahead of listing on Nasdaq

Tilray, a Canadian marijuana company owned by Seattle private equity firm Privateer Holdings, unveiled the terms of a previously announced initial public offering. The British Columbia-based company, which filed for the IPO last month, plans to issue 9 million shares of its common stock priced between $14 and $16 (CA$18.40 and  CA$21) a share. The IPO […]

Read More

Canadian cannabis company Tilray files for IPO, eyes Nasdaq listing

Tilray, the British Columbia cannabis company owned by Seattle private equity firm Privateer, filed paperwork with the U.S. Securities and Exchange Commission on Wednesday to go public. The vertically integrated grow, processing and distribution company – one of the bigger cannabis companies in Canada – intends to list on the Nasdaq Global Select Market under […]

Read More

Unit of big pharmaceutical firm Novartis partners with medical marijuana producer Tilray

British Columbia-based medical marijuana producer Tilray announced Monday it has formed a strategic partnership with Sandoz Canada, the first known affiliation between a marijuana producer and a major pharmaceutical company. Tilray signed a letter of intent with the Quebec-based affiliate of Sandoz International GmbH, an arm of global health care giant Novartis. The entry of […]

Read More